Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these receptors, Retatrutide controls cravings, {promotesglucose regulation, and ultimately leads to significant slimming. While studies are stil